Rubella is a viral disease caused by rubella virus and described as an acute illness, historically also called German measles [1][2]. The source characterization emphasizes a febrile rash illness with the potential for congenital infection when primary maternal infection occurs in early pregnancy [1]. Rubella is therefore relevant both as an individual viral exanthem and as a preventable cause of congenital disease [1].
Disease Profile
Rubella
风疹
Rubella is an acute viral illness caused by rubella virus and classically associated with fever and rash [1]. It is often clinically mild, but infection in early pregnancy can lead to congenital rubella syndrome, a condition with serious medical and public-health consequences [1]. Source-backed detail on the full spectrum of population burden is limited here, although WHO estimates cited in the source place congenital rubella syndrome at approximately 100,000 cases per year [1].
The typical clinical picture is a mild, self-limited illness with fever, a generalized erythematous maculopapular rash, and lymphadenopathy [1]. A substantial proportion of infections are asymptomatic, with the source estimating this at 25-50% [1]. Reported complications include arthralgia, arthritis, thrombocytopenic purpura, and encephalitis [1]. Congenital rubella syndrome is associated with cataracts, sensorineural hearing impairment, congenital heart disease, jaundice, purpura, hepatosplenomegaly, and microcephaly [1].
The source notes that congenital rubella syndrome remains a major public-health concern, with WHO estimating approximately 100,000 cases per year [1]. Rubella vaccination coverage was reported at 70% globally in 2020, indicating incomplete population-level protection in the source material [1]. The available snippets do not provide detailed country-specific incidence patterns, seasonality, or outbreak geography, so those data are not yet available from the provided evidence [1].
Rubella virus is transmitted through respiratory droplets and direct contact [1]. The provided material does not further define the relative importance of these routes, environmental persistence, or the duration of infectiousness, so source-backed detail beyond these routes is not yet available [1].
The clearest source-defined high-risk group is pregnant people with primary rubella infection in early pregnancy, because this exposure can result in congenital rubella syndrome [1]. The material also indicates that asymptomatic infection is common, which complicates recognition of cases in the wider population [1]. No additional risk-group stratification is supported by the supplied snippets, so further subgroup detail is not yet available [1].
Rubella and congenital rubella syndrome can be prevented by rubella-containing vaccines, which are commonly given in combination with measles vaccine [1]. The provided sources also note that public debate and reduced vaccination coverage in some settings have persisted despite the vaccine’s accepted effectiveness [3]. No source-backed details are available here on schedule, catch-up strategy, or other exposure-control measures [1][3].
In surveillance terms, rubella should be interpreted not only as a usually mild febrile rash illness but also as a marker of preventable congenital risk [1]. Because a large fraction of infections may be asymptomatic, case counts may underrepresent circulation in the population [1]. Monitoring should therefore consider both acute rubella and congenital rubella syndrome burden, while recognizing that the provided sources do not supply further operational surveillance guidance [1].
- 1 Winter AK et al. Rubella. Lancet. 2022 Apr 2. PMID: 35367004. doi: 10.1016/S0140-6736(21)02691-X. PubMed: https://pubmed.ncbi.nlm.nih.gov/35367004/
- 2 Rubella. Clinical Neurovirology. 2020. doi: 10.1201/9781315113913-23. DOI: https://doi.org/10.1201/9781315113913-23
- 3 Di Pietrantonj C et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22. PMID: 34806766. doi: 10.1002/14651858.CD004407.pub5. PubMed: https://pubmed.ncbi.nlm.nih.gov/34806766/
- 4 Gidengil C et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine. 2021 Jun 23. PMID: 34049735. doi: 10.1016/j.vaccine.2021.03.079. PubMed: https://pubmed.ncbi.nlm.nih.gov/34049735/
- 5 German Measles and German Measles in Pregnancy. Archives of Pediatrics & Adolescent Medicine. 1957. doi: 10.1001/archpedi.1957.02060040557010. DOI: https://doi.org/10.1001/archpedi.1957.02060040557010
- 6 German Measles. Encyclopedia of Autism Spectrum Disorders. 2021. doi: 10.1007/978-3-319-91280-6_300749. DOI: https://doi.org/10.1007/978-3-319-91280-6_300749
- B06
- KA63
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
Australia
Australian national notifiable diseases surveillance dashboard.
Official sourceSwitzerland
Switzerland FOPH/BAG IDD mandatory reporting API normalized to national case rows. Monthly series may use the dashboard CHFL aggregate where CH-only monthly series are not exposed.
Official sourceChina
Monthly notifiable infectious disease reports published by China CDC.
Official sourceChina
Official China public health bulletin and query portal.
Official sourceChina
Biomedical literature discovery feed used as supplementary context.
Official sourceHong Kong, China
Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals
Official sourceJapan
Japan weekly infectious disease surveillance via NIID/JIHS.
Official sourceSouth Korea
Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.
Official sourceNew Zealand
PHF Science (formerly ESR) monthly notifiable disease surveillance data via internal globalID2 crawler
Official sourceTaiwan, China
Taiwan, China monthly notifiable infectious disease open-data CSV feed.
Official sourceUnited States
CDC National Notifiable Diseases Surveillance System provisional data.
Official source